| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |